Benutzer: Gast  Login
Dokumenttyp:
Zeitschriftenaufsatz
Autor(en):
Wykoff, Charles C; Abreu, Francis; Adamis, Anthony P; Basu, Karen; Eichenbaum, David A; Haskova, Zdenka; Lin, Hugh; Loewenstein, Anat; Mohan, Shaun; Pearce, Ian A; Sakamoto, Taiji; Schlottmann, Patricio G; Silverman, David; Sun, Jennifer K; Wells, John A; Willis, Jeffrey R; Tadayoni, Ramin; Aaberg, Thomas, Jr; Abbey, Ashkan; Abdulaeva, Elmira; Abengoechea, Santiago; Abraham, Prema; Ach, Thomas; Adams, Serrhel; Adan Civera, Alfredo; Adrean, Sean; Agostini, Hansjurgen; Alam, Suhail; Alezzandrini,...     »
Titel:
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
Zeitschriftentitel:
The Lancet
Jahr:
2022
Band / Volume:
399
Heft / Issue:
10326
Seitenangaben Beitrag:
741-755
Volltext / DOI:
doi:10.1016/s0140-6736(22)00018-6
Verlag / Institution:
Elsevier BV
E-ISSN:
0140-6736
Publikationsdatum:
01.02.2022
 BibTeX